Forty-one HIV-1 strains from Gabonese patients were studied according to the following strategy: nested polymerase chain reaction were performed to obtain an approximately 1100-bp fragment containing the protease gene and the 59 half of the reverse transcriptase gene. Additional amplifications were carried out to obtain an approximately 700-bp fragment encompassing the C2V3 env gene. Fragments of 600 to 1200 bp in the gag gene overlapping the pol sequences were used for the study of recombination patterns. Phylogenetic analyses of the different fragments were used to investigate HIV-1 diversity in Gabon. Thirty-one strains were sequenced in the env and pol genes and phylogenetic analyses classified them as subtype A (n 5 2), D (n 5 4), G (n 5 1), H (n 5 1), CRF02 (n 5 8), and CRF MAL-like (n 5 6); in addition, there were 6 unique recombinant forms and 1 unclassified strain, and in 2 cases pol/env sequences classified strains as subtype D whereas gag phylogeny classified them as subtype A. In 10 cases only 1 fragment was available: 4 env (2 subtype D, 1 subtype H, and 1 subtype U) and 6 pol (1 subtype A, 1 subtype C, 2 subtype G, and 2 subtype U). Minor mutations associated with viral resistance to antiretroviral drugs were observed in more than 80% of analyzed strains. Our study confirms the extensive HIV-1 diversity found in Central Africa, with more than 70% of strains from Gabon exhibiting discordant clustering in pol and env genomic regions and less than 60% concordance between sequencing and heteroduplex mobility assay genotyping. These findings highlight the fact that Central Africa represents the epicenter for the origin of HIV-1. The strategy of sequencing pol in association with env has proved to be useful for analysis of the recombinant strains. The main advantage of this approach is that it also allows for evaluation of genotypic susceptibility to antiretroviral drugs without the need for supplementary analyses. 1103 
INTRODUCTION P
HYLOGENE TIC ANALYSES have identified three human immunodeficiency virus type 1 (HIV-1) lineages that have been named group M (main), group O (outlier), and group N (non-M/non-O). 1 Group M, which comprises the majority of circulating HIV-1 strains worldwide, is further classified into nine subtypes (A-D, F-H, J, and K), subsubtypes (A1/A2 and F1/F2), circulating recombinant forms (CRFs) (CRF01 to CRF14), and unclassified (U) strains.
1,2 Recombinant viruses not fulfilling the CRF criteria have also been reported. [3] [4] [5] [6] The oldest strains isolated from Africa for which complete genomic sequences are available, MAL and Z321, have themselves been shown to be complex recombinants. 7, 8 Viral diversity represents a significant challenge for screening and clinical monitoring of HIV infection: (1) serological tests fail to reliably detect infection with group O viruses 9 nonsubtype B strain early seroconversion, 10 or to quantify the p24 antigen of nonsubtype B viruses in cell cultures of recently infected individuals 11 ; (2) viral load assays used to monitor clin-ical evolution and treatment efficiency in HIV-infected patients may fail to quantify nonsubtype B sequences 12, 13 ; and (3) HIV-1 group O strains are naturally resistant to nonnucleoside reverse transcriptase inhibitors, similar to some HIV-1 group M strains, 14, 15 whereas naturally occurring reduced susceptibility to protease inhibitors was reported for subtype G strains. 16 All these fallibilities concern only HIV-1 nonsubtype B strains and are due to the development of diagnostic tests and antiretroviral drugs in Western countries, where subtype B strains prevail. 1 Biological consequences of HIV-1 diversity have also been reported, although not always confirmed. [17] [18] [19] However, despite the fact that diversity does not seem to influence virus biology in any way that correlates neatly with HIV-1 nomenclature, subtype classification represents the most important means of tracking virus distribution and its evolution during the pandemic 20 and will clearly have a major influence on the design of an effective anti-HIV-1 vaccine. 21 Full-length sequencing is required for the definition of new subtypes or CRFs 2 and permits the pattern of mosaicism to be determined. 22 However, this method is time-consuming and expensive, requires qualified personnel, and can be done only with well-preserved samples, which precludes its use for monitoring the distribution of HIV strains worldwide. Alternative methods for the study of HIV diversity are widely used in developing countries, such as serological discrimination, heteroduplex mobility assay (HMA), or subtype-specific polymerase chain reaction (PCR). [22] [23] [24] Nevertheless, sequencing remains the most accurate approach to identify HIV-1 variants. Sequencing partial env and gag sequences is more accurate than analysis of the env gene alone for the detection of clusters of viruses or recombinants. However, sequencing pol instead of gag seems more appropriate for the detection of recombinant forms of HIV-1, as phylogenetic analyses of the pol gene permit reliable subtype classification 15, 25 and yield information concerning the genotypic susceptibility to antiretroviral drugs. 26 All but two CRFs described to date exhibits recombination break points in the first half of the pol gene, 1 which has been reported to be a possible "hot spot" for recombination. 27 Gabon is a West Central African country in which HIV-1 seems to be endemic, with a relatively stable prevalence of infection and high strain diversity. 28 In 1998 we investigated HIV-1 diversity in Gabon by HMA genotypic screening 29 and observed a high proportion of subtype A strains. These results contrasted with previously reported data on HIV-1 diversity in Gabon and with more recent reports revealing a large circulation of CRF_02 IbNG in West Central African countries. 30 We thus sequenced a set of 42 HMA-genotyped strains to evaluate the reliability of this technique for genotypic screening in Central Africa. We also evaluated the usefulness of sequence analysis of the protease gene and the first half of the reverse transcriptase gene combined with the analysis of env fragments for both the detection of recombinants and genotypic drug susceptibility analyses.
MATERIALS AND METHODS

Patients
Forty-one HIV-1-positive samples collected between 1996 and 1999 were genetically characterized. These samples originated from different geographical regions of Gabon: 27 from the southeast (Franceville, 10; Moanda, 16; and Okondja, 1), 4 from the northwest (Libreville), 3 from the southwest (Port Gentil), and 2 from the northeast (Makoukou). In addition, five samples from foreign patients living in Gabon and originating from neighboring Central African countries (two from Cameroon and one each from Togo, Congo, and Equatorial Guinea, respectively) were included. Nineteen samples were from females and 22 were from males. Almost all of the included patients reported heterosexual transmission as the risk factor for HIV-1 infection. Five patients had received transfusions in the past. Twenty-two patients exhibited clinical signs of infection (n 5 13), tuberculosis (n 5 8) or sexually transmitted disease (n 5 1). Eleven patients were diagnosed during seroepidemiological screenings, whereas 9 were blood donors. Most of the patients were young adults aged 20 to 30 years and only 2 of the 36 Gabonese patients had traveled outside Gabon.
HMA results on the included strains were as follows: subtype A (n 5 10), subtype D (n 5 6), subtype H (n 5 5), subtypes C and F (n 5 2 each), and subtypes B and G (n 5 1 each). In 14 cases HMA results were indeterminate, with dually reactive patterns (3 A/G, 1 D/B, 1 C/G, 1 A/F, and 1 Ind/A) or nonreactive patterns (n 5 7).
PCR and sequencing
Sequencing of the 59 half of the pol gene. Two overlapping fragments encompassing the protease and the first half of the RT gene were amplified with different sets of primers (Fig. 1) . A 485-bp fragment encompassing the protease gene was amplified in a nested PCR with outer primers 59PROT1/39PROT1 and inner primers 59PROT2/39PROT-2, 31 using previously reported PCR conditions. Sequencing was performed on products amplified with the inner primers. The first half of the RT gene (,900 bp) was amplified in a nested PCR with outer primers RT-18/RTout and inner primers RT-19/RT-20 as described. 32 Nested PCR products were subjected to direct population sequencing with sense primer A 20 and antisense primer NE1 20 . The two fragments were overlapped to obtain an approximately 1100-bp fragment in the 59 half of the pol gene.
Sequencing of the envelope V3-V5 region. The env genetic subtype was determined by direct sequencing of the V3-V5 region of the envelope (700 bp). PCRs were carried on by using outer primers ED5/ED12 or ED3/ED14 and inner primers ES7/ES8 23 under PCR conditions as reported. 4 Primers ES7 and ES8 were used for sequencing.
Sequencing of the gag region. To obtain gag-pol contiguous fragments for diversity plot analyses of strains presented discordant pol-env clustering, two overlapping fragments were amplified in the gag gene. Thirteen samples were amplified by a nested PCR using outer primers gagA/gagB and inner primers gagC/gagF and PCR conditions as reported. 33 An 830-bp fragment of the gag gene was amplified by a nested PCR using inner primers HIG822/HIGHMA1317 as reported 34 on an XL-PCR product (see below). Enlargements showing subgenomic gag, pol, and env fragments that were amplified by PCR and sequenced.
XL-PCR.
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LSiGi and thereafter by using the inner primers described above for each region. PCR conditions for the XL-PCR included a hot start (94°C for 3 min) with the following cycling conditions: 16 cycles of denaturation at 94°C for 30 sec, annealing at 55°C for 1 min, and extension at 68°C for 10 min, followed by 24 cycles with extension at 68°C for 10 min with an increment of 20 sec per cycle. Amplification was completed by a final extension at 68°C for 12 min. Two microliters of the product was subsequently amplified in different nested PCRs as described above. All PCRs were carried out with a Roche PCR kit (Roche Diagnostics, Mannheim, Germany), 2.5 U of Taq polymerase, and 10 pmol of each primer per reaction. For the XL-PCR we used a Perkin Elmer amplification kit (GeneAmp XL PCR kit; PerkinElmer, Foster City, CA). The amplified products were detected by electrophoresis on 2% agarose gels and visualized by staining with ethidium bromide (0.05%). The PCR amplicons were purified directly from the PCR mix or from gels, using a QIAquik gel extraction kit (Qiagen, Courtaboeuf, France). Sequencing reactions for all amplified fragments were performed with an ABI PRISM dye terminator cycle sequencing Ready Reaction kit with AmpliTaq DNA polymerase (PerkinElmer) on an automated sequencer (373A; PE Biosystems, Foster City, CA).
Phylogenetic analysis
The gag, pol, and env nucleotide sequence alignments were obtained from the Los Alamos National Laboratory HIV Sequence Database (http://hiv-web.lanl.gov). Newly derived Gabonese sequences were aligned with the latter alignments, using the CLUSTAL W 35 profile alignment option. The resulting alignments were adjusted manually where necessary. Regions of ambiguous alignment and all gap-containing sites were excluded.
Phylogenetic trees were inferred from the nucleotide alignments by the neighbor-joining method, 36 using the HKY85 model of nucleotide substitution 37 implemented with PAUP*. 38 The reliability of branching order was assessed by performing 1000 bootstrap replicates, again using neighbor joining and the HKY85 model. Phylogenetic trees were also inferred by maximum likelihood, using PAUP*, with the HKY85 model incorporating an estimate of the transition: transversion ratio and an a shape parameter (using eight discrete categories) for a g distribution of rate heterogeneity among sites, both estimated on the basis of the neighbor-joining tree. The neighbor-joining tree topology was used as the starting tree in a heuristic search, using Nearest Neighbor Interchange (NNI) followed by Tree Bisection/Reconnection (TBR) branch swapping.
Antiretroviral drug resistance patterns
To investigate the antiretroviral drug resistance patterns of the strains, protease and RT sequences were translated and compared with the reference subtype B strain on which resistance mutations were established. Mutations associated with viral resistance were then evaluated according to the recommendations of the USA Panel of the International AIDS Society. 26 
RESULTS
PCR amplification and strain analysis
env gene subtyping. The V3-V5 region of envelope was amplified in 35 of the 42 specimens and these were sequenced. In the remaining seven patients env amplification could not be carried out because the samples were exhausted. An env phylogenetic tree based on 455 sites, showing the relationships between the 35 Gabonese partial envelope sequences and reference strains, is presented in Fig. 2A (Fig. 2) , with MAL being the closest reference strain. These phylogenetic relationships were confirmed in the env tree inferred by maximum likelihood (ML) (data not shown).
env Fig. 2A) . Seven of the 12 env subtype A strains were correctly identified by HMA, the remaining strains being typed as subtype F (n 5 2), A/G (n 5 2), or indeterminate (n 5 1). Conversely, all five subtype H strains were correctly typed by HMA as subtype H. For the remaining strains, HMA results were correlated with se- Ind quencing only in the case of the subtype C strain. U strains were genotyped as subtype A by HMA, whereas the subtype G strain was indeterminate by HMA. No association was seen between env genetic subtype and age or sex, but there were some relationships between the env sequencing and geographical location of patients: of the 14 env subtype D strains characterized, all but one originated from eastern parts of Gabon. Three of the five subtype H strains originated from the west coast. Both U strains originated from remote areas in east Gabon. Sequencing of the env gene was carried out in three of the five samples from foreign patients included in the study. All these sequences clustered within subtype A, two of them in the IbNG group. However, one should note that the sample number is too low to allow a correlation between subtype prevalence and geographic origin of patients.
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pol gene subtyping. pol sequences were available for 37 patients. Both protease and reverse transcriptase sequences were available for 28 patients. In seven cases only RT sequences were available, whereas in two cases only the protease gene was sequenced. After assigning subtype classification, protease sequences (97CIRMF04 and 97CIRMF43, both subtype G) were excluded from phylogenetic analysis and trees were inferred by using 703 sites in the first half of the RT sequence (Fig. 2B) . Eleven strains fell within subtype G, of which 8 were grouped together with the IbNG strain. This pattern of grouping was more evident when trees were constructed with the whole pol fragment (1055 sites after gap stripping) also containing the protease gene (data not shown). Six strains clustered with a high bootstrap value (92%) with MAL and NOGIL3 strains in the pol tree, forming a separate subcluster close to subtype K (Fig. 2B) . Six strains were classified as subtype D, two as subtype C, and one as subtype H, whereas for five strains, exhibiting different branching patterns, a subtype assignment was impossible (Fig. 2B) . These phylogenetic relationships were confirmed in the pol tree inferred by ML (not shown).
Recombination patterns as detected by comparative analyses of the gag, pol, and env genes and diversity plot analyses.
Phylogenetic analyses of the structural genes of the Gabonese strains showed a complex pattern of diversity (Table 1) . Of the 31 strains for which pol-env fragments were available, only 11 strains exhibited a similar subtype clustering in the two trees. Six strains were classified as subtype D by the two analyses. gag sequences were also available for four of these six cases and classified two strains (97CIRMF07 and 97CIRMF08) as subtype A (data not shown), showing their recombinant nature. In a third case (97CIRMF05) a contiguous gag-pol fragment of 2115 sites was available and diversity plots confirmed its phylogenetic classification as subtype D (data not shown). The last strain (97CIRMF27) clustered within subtype D in all three phylogenetic trees, but diversity plot analysis of a 2296-site fragment revealed that strain 97CIRMF27 contains U fragments in the second part of gag (Fig. 3a) . Two strains (97CIRMF21 and 96CIRMF62) have been classified as subtype A by pol-env phylogenetic analyses. gag gene was available for the last one, and diversity plot analysis of a contiguous gag-pol fragment of 1686 bp showed that it contains U fragments in the second part of gag (data not shown). One strain (97CIRMF09) was classified as subtype G by gag-pol analysis. Both the gag phylogenetic tree and diversity plot analysis of a contiguous fragment of 2076 bp confirmed the subtype G classification for this strain. The remaining strains (97CIRMF25 and 97CIRMF71) have been classified as subtypes H and C, respectively. A gag fragment was available for 97CIRMF71 and was classified as subtype A by phylogenetic analysis (data not shown).
For nine strains, phylogenetic analyses generated A env /G pol discordant patterns and the strains clustered with the CRF_02 strains in the phylogenetic trees. gag sequences were available in three of these nine cases and confirmed that two of them (97CIRMF35 and 97CIRMF38) had similar breaking points with CRF_02, which has an A/G structure in the analyzed region (data not shown). A third case (97CIRMF58) presented an A gag /CRF_02 pol /A pol structure, as shown by phylogenetic analyses. A diversity plot of 2064-bp gag-pol fragment showed a subtype A insert in the middle region of the analyzed sequence (Fig. 3b) .
Different patterns of recombination, as yet unassigned to a defined CRF, have been observed for the remaining strains: Table 1) . One strain (97CIRMF02) was assigned a U pol /U env classification by phylogenetic analysis. Diversity plot analysis of a contiguous 2064-bp gag-pol fragment depicted a complex pattern of recombination and is presented in Fig. 3c .
Six strains presented a K pol /D env structure by phylogenetic analyses and were grouped with the MAL strain in the phylogenetic trees. As MAL has three recombination break points in the first half of the pol gene, 39 this pattern of clustering is highly consistent with an MAL-like structure. In four cases gag sequences have also been available and in two cases contiguous gag-pol fragments of 2382 sites (97CIRMF44) and 2070 sites (99CIRMF01), respectively, have been available. The relationships between these two strains and other subtype representative strains from the database were further investigated by concatenating the gag-pol contiguous fragments and comparing these strains with subtype representative strains. For both Gabonese strains the closest sequences were MAL and NOGIL3 (Fig. 3d) . Such a similarity in pairwise genetic distances between sequences is indicative of similarity of the break points, a criterion in use for the definition of a CRF. 2 Altogether, our results indicate the circulation of at least six different subtypes and two CRFs in Gabon. The main recombinant form is CRF_02, which was present in nine patients (21%). Some other recombinant strains seemed to share similar structure, most notably the MAL-like forms (n 5 6, 14%). In six cases (14%) unique recombinant viruses were detected.
Resistance to antiretroviral drugs
Protease and the 59 half of reverse transcriptase sequences were translated to amino acids in order to evaluate the frequency of naturally occurring resistance mutations toward antiretroviral drugs (Fig. 4) . The amino acid sequence of each strain was compared with the reference sequence for mutations associated with resistance to protease inhibitors (PIs). 26 No major mutations (D30N, G48V, I50V, V82A/T/F, I84V, or L90M) were seen in any of the analyzed samples. Several accessory mutations associated with resistance to PIs were observed in different positions: M36I (n 5 24; 80%), L63P (n 5 8; 27%), L10V 
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(n 5 5; 17%), K20M/R (n 5 1; 3%), and V77I (n 5 ; 3%). The mutation G16E, associated with resistance to ABT378, 40 was observed in two strains. The occurrence of these mutations was not associated with a given subtype (Fig. 4) . Globally, at least one accessory mutation associated with drug resistance was observed in all the analyzed strains. Four strains had two minor mutations associated with resistance and one strain presented three. Amino acid substitutions, which differed from those linked to PI resistance, were observed at key positions. K20I was observed in 13 (43%) strains (8 CRF_02, 2 G, and 3 U). Other mutations, already reported to occur in the protease gene, and never associated with drug resistance but with protease polymorphism, were observed: M36L (n 5 6; 20%), L63T/A/S/Q (n 5 6; 20%), and V82I (n 5 8; 27%).
None of the strains had major mutations associated with resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Viral polymorphism occurred in a codon associated with resistance to nevirapine (V106I) in two strains (96CIRMF41 and 97CIRMF27), but involved a different amino acid than that associated with phenotypic resistance to this nonnucleoside compound. Several other patterns of polymorphism were observed: P236S (97CIRMF05) and V118A (97CIRMF38). Two strains (97CIRMF44 and 97CIRMF38) presented an accessory mutation to zidovudine (K219Q). All the pol subtype D strains from Gabon harbored the V118I substitution, which was reported to associate a moderate (10-fold) increase in phenotypic susceptibility to lamivudine.
26
DISCUSSION
Identification of a high prevalence of HIV-1 group M recombinant viruses in Gabon
Our results confirm the high viral diversity in Gabon, 28 showing the cocirculation of at least seven different viral lineages in different regions of this country. Most of the analyzed strains showed different clustering patterns in different regions of the genome, which corroborate previous studies showing the high prevalence of recombinant strains in Central Africa. 4 This shows that sequencing of at least two genes is necessary for characterization of HIV-1 diversity in this region.
Nine of 41 strains (22%) clustered with the IbNG-like strains, similar to previous reports. 30 All of these strains were analyzed in pol, the genome region in which the CRF02_AG presents break points and has mostly a subtype G structure. 1 A tenth strain (97CIRMF58) clustered with CRF02_AG in pol but presented different branching in gag, suggesting an A/CRF02 recombinant strain (Table 1) ; this is not surprising, as numerous studies reported that different patterns of recombination between the parental A and G subtypes are cocirculating with CRF02 in West Central Africa. 41, 42 The remaining discordant strains exhibited different patterns of recombination, not associated with any of the CRFs described to date. Most of these samples (n 5 6) exhibited an A gag /K pol /D env structure. Both pol phylogenetic analysis and the analysis of recombination in the gag-pol fragments revealed that the closest relative of these Gabonese strains was MAL (Figs. 2b and 3d ). In the first half of the pol gene MAL has an A/D/U/K/U structure, 39 and therefore these viruses share four recombination break points. Thus, our results strongly suggest that the Gabonese strains, together with MAL, originate from a single common ancestor. One should note that the NOGIL cluster consists of strains sharing structural features with the MAL strain, except for the env gene, which has a subtype H structure. 43 We have also observed different patterns of recombination involving MAL-like strains ( Table 1 ). The existence of this CRF "MAL" is strongly supported by our results even in the absence of complete genome sequences requested for the definition of a new CRF.
The circulation of MAL-like viral forms in Central Africa has generic significance for the contribution of HIV-1 recombinants to the pandemic. It is often assumed that the large distribution of the CRFs in new epidemics is a result of these recombinant viral forms having a competitive advantage over nonrecombinant forms, and thus being more readily transmitted. 22 For example, some of the CRFs have generated explosive epidemics in Asia, the former Soviet Union, and in West and Central West Africa. 30, 41 However, MAL is one of the oldest African isolates, 44 and therefore our finding of MAL-like recombinants indicates that CRF-MAL was circulating in Africa at this time. The circulation of old recombinant strains in Central Africa, the epicenter of the AIDS emergence, suggests that CRFs do not necessarily have a real epidemiological advantage over the "pure" viral forms. Recombinant strains are uniformly represented in different countries in this region and many of them do not belong to any of the already defined CRFs. [3] [4] [5] [6] 45 The explosive spread of recombinant forms in the pandemics is thus simply due to the penetration of risk groups, that is, chance epidemiological events, rather than to any competitive advantage, analogous to the establishment of the subtypes. 46 Classification difficulties in Central Africa: the fallibility of HMA High intrasubtype diversity is probably the reason for the low efficiency of the HMA as a method for genotype screening. In our study, only 53% of samples were genotyped by HMA, which is significantly lower than that reported for countries where the epidemic has evolved rapidly 30, 47 but similar to results already reported for another Central African country, the Democratic Republic of Congo (DRC). 4 The lack of correlation between sequencing and HMA genotyping for the subtype D strains is not surprising. In a previous study we have reported that current subtype D HMA plasmids are not adapted for the detection of subtype D strains from Central Africa. 48 Similarly, the correct identification of subtype H could be related to the design of plasmid used for the detection of this subtype based on strains isolated in Central African countries. 49 
Advantages of a sequencing strategy including pol analysis for the study of HIV-1 diversification and drug susceptibility survey
For the study of HIV-1 diversity in Gabon, we have used a strategy designed for the concomitant investigation of viral diversity, recombinant strain prevalence, and genotypic drug susceptibility analysis. Several other groups of investigators have proposed different strategies, including pol sequencing for the study of HIV-1 diversity, based on (1) sequencing of the integrase associated with env C2-V3 regions of HIV-1 50 ; (2) use of protease and/or RT sequences routinely obtained from treated patients to evaluate mutations associated with reverse transcriptase or protease inhibitors, for the characterization of the infecting subtype 25, 51 ; (3) analysis of the protease gene combined with either C2-V3 env or p24 gag genes. 52 The approach that we have used here, however, seems better adapted to the study of diversity because the pol fragment we analyzed is long enough to permit both reliable subtype discrimination and/or study of recombinant structure, and the genotypic drug susceptibility analyses of a given strain. All but two CRFs described to date present break points in this region and, as we have shown in our study, such analysis allows us to establish similarities between different strains and to point out those strains sharing similar recombination structures. Additional amplifications of the 39 end of the gag gene, which overlaps with the 59 end of the pol gene, can be performed to obtain sequence fragments long enough for further analysis. Our strategy can also be adapted for different purposes. We have already used it for the analysis of viral resistance mutations in an epidemic characterized by a high homogeneity of strains, for which a founder effect of a strain containing drug resistance mutations would have severe implications for antiretroviral treatment efficiency. 53 In the present study, we have applied it for evaluation of the prevalence of recombinant strains of HIV in an endemic region for HIV-1 infection. In both situations the strategy proved to be effective.
In conclusion, several common features are shared by the HIV-1 epidemics in Gabon and other Central African countries. In this region, high genetic diversity is paralleled by low and stable HIV-1 seroprevalence. The high number of HIV-1 cocirculating subtypes, and the high intrasubtype diversity together with a high prevalence of recombinant viruses and different unclassified strains, are consistent with an old epidemic in Central Africa, which is probably the epicenter of HIV-1 group M emergence. 4, 46 
